Trials / Unknown
UnknownNCT02806531
Safety Study of Enterovirus 71 Vaccine in Children Aged 6-35 Months Old
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20,000 (estimated)
- Sponsor
- Beijing Chaoyang District Centre for Disease Control and Prevention · Academic / Other
- Sex
- All
- Age
- 6 Months – 35 Months
- Healthy volunteers
- Accepted
Summary
This phase IV clinical study evaluates the safety of enterovirus 71 vaccine in children aged 6-35 months old by the method of both passive and active surveillance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | two doses enterovirus 71 vaccine | Two doses of enterovirus 71 vaccine will be given in children aged 6-35 months old, 28 days interval. |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2018-07-01
- First posted
- 2016-06-20
- Last updated
- 2016-06-20
Source: ClinicalTrials.gov record NCT02806531. Inclusion in this directory is not an endorsement.